New Delhi, May 5 (IANS) Vaccinating pregnant women against whooping cough can boost the quantity and quality of antibodies in the early life of infants, according to a study.
Whooping cough, also known as pertussis, is a highly contagious respiratory infection characterised by severe coughing spells that can end in a high-pitched “whoop” when inhaling. It is caused by the bacteria Bordetella pertussis.
Despite extensive vaccinations, the disease has resurged. The World Health Organization (WHO) estimates that there are 16 million cases annually and approximately 195,000 deaths in children globally.
Researchers at the University of Turku in Finland conducted a randomised, controlled, double-blind, phase 4 trial in Gambia to evaluate the effect of pertussis immunisation in pregnancy.
Two types of pertussis vaccines are currently used worldwide: whole-cell vaccines (wPVs) based on killed whole bacteria and acellular vaccines (aPVs) based on one to five purified bacterial antigens.
The findings, published in The Lancet Infectious Diseases, demonstrated that vaccinating women with diphtheria-tetanus-acellular pertussis vaccines in pregnancy was safe and well tolerated and boosted the quantity and quality of pertussis-specific antibodies in infants in early life.
Since the highest incidence and mortality of pertussis occur in infants, especially those too young to be vaccinated, immunisation in pregnancy (IP) is recommended to protect infants in early life against pertussis.
However, studies have shown that IP can decrease the antibody responses of infants to their primary diphtheria-tetanus-acellular pertussis (DTaP) vaccination. This phenomenon is called “blunting.”
Blunting of vaccine responses has been observed in IgG-antibody concentrations to different pertussis vaccine antigens, specifically, pertussis toxin, filamentous hemagglutinin, pertactin, and diphtheria toxin.
“This study was designed to evaluate the effect of IP on the immunogenicity of primary acellular or whole-cell pertussis vaccines in a West African cohort,” said the researchers led by Qiushui He, a Professor, at the varsity, who found the vaccine to be effective.
“Although Tdap-IPV (Tetanus, diphtheria, acellular pertussis, polio vaccine) was associated with relative blunting of the immune response to the DTwP (Diphtheria-Tetanus-whole-cell pertussis) primary vaccination series, pertussis-specific antibody quality and memory B-cell responses were nevertheless preserved,” the team added.
–IANS
rvt/
Disclaimer
The information contained in this website is for general information purposes only. The information is provided by BhaskarLive.in and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.
In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.
Through this website you are able to link to other websites which are not under the control of BhaskarLive.in We have no control over the nature, content and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.
Every effort is made to keep the website up and running smoothly. However, BhaskarLive.in takes no responsibility for, and will not be liable for, the website being temporarily unavailable due to technical issues beyond our control.
For any legal details or query please visit original source link given with news or click on Go to Source.
Our translation service aims to offer the most accurate translation possible and we rarely experience any issues with news post. However, as the translation is carried out by third part tool there is a possibility for error to cause the occasional inaccuracy. We therefore require you to accept this disclaimer before confirming any translation news with us.
If you are not willing to accept this disclaimer then we recommend reading news post in its original language.
